Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia
Clinical trial NCT04226950 · UNKNOWN
Trial details
- NCT number
- NCT04226950
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-10
- Primary completion
- 2024-10-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.